In review: the life sciences regulatory regime in Finland

This article reviews the essential regulatory considerations surrounding medicines and medical devices in Finland, including clinical trials and marketing authorisations.

Related Keywords

Finland ,Finnish , ,National Committee On Medical Research Ethics ,European Commission ,Council Regulation ,European Federation Of Pharmaceutical Industries ,Gene Technology ,International Federation Of Pharmaceutical Manufacturers ,European Medicines Agency ,Clinical Research ,Medicines Act ,Medicines Decree ,Pharma Industry Finland ,European Federation ,Pharmaceutical Industries ,International Federation ,Pharmaceutical Manufacturers ,Finnish Medical Devices Act ,Finnish Act ,Certain Medical Devices ,Medtech Finland ,Medtech Europe Code ,Finnish Consumer Protection Act ,Unfair Practices ,Customer Relations ,Medical Research Act ,Animals Used ,Educational Purposes ,Animal Welfare Act ,Gene Technology Act ,Clinical Trials Regulation ,Member State ,Data Protection Regulation ,National Committee ,Medical Research Ethics ,Medicines Directive ,Medicinal Products ,Medical Devices Act ,European Medicines ,Patent Act ,Finnish Patent Act ,Pharmacovigilance Directive ,Manufacturing Practice ,Supervisory Commission ,Medical Devices ,Military Pharmacy ,Medical Device Act ,European Economic Area ,Narcotics Act ,Finnish Decree ,Consumer Market ,Finnish Criminal Code ,Law ,Lawyers ,Legal ,Aw Firms ,Aw Updates ,Egal Updates ,Egal Developments ,Aw Developments ,Egal Newsletters ,Egal Current Awareness ,Deals ,Egal Advisers ,Egal Advisors ,Egal Directory ,Ealthcare Amp Life Sciences ,